Invention Grant
US08420657B2 Pyrrolo[2,3-D]pyrimidines and use thereof as tyrosine kinase inhibitors
失效
吡咯并[2,3-D]嘧啶及其作为酪氨酸激酶抑制剂的用途
![Pyrrolo[2,3-D]pyrimidines and use thereof as tyrosine kinase inhibitors](/docs/US/2013-04-16/US08420657B2/abs.jpg.600x600.jpg)
- Patent Title: Pyrrolo[2,3-D]pyrimidines and use thereof as tyrosine kinase inhibitors
- Patent Title (中): 吡咯并[2,3-D]嘧啶及其作为酪氨酸激酶抑制剂的用途
-
Application No.: US12366218Application Date: 2009-02-05
-
Publication No.: US08420657B2Publication Date: 2013-04-16
- Inventor: Christoph Gaul , Marc Gerspacher , Philipp Holzer , Carole Pissot Soldermann
- Applicant: Christoph Gaul , Marc Gerspacher , Philipp Holzer , Carole Pissot Soldermann
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Laura K. Madden
- Priority: EP08151137 20080206
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61K31/519 ; A61P35/02 ; A61P37/06 ; A61P35/04 ; A61P25/28
![Pyrrolo[2,3-D]pyrimidines and use thereof as tyrosine kinase inhibitors](/abs-image/US/2013/04/16/US08420657B2/abs.jpg.150x150.jpg)
Abstract:
The invention relates to compounds of formula I and salts thereof wherein the substituens are as defined in the specification, processes for the preparation thereof; to pharmaceuticals containing such compounds, in particular for the use in one or more Protein tyrosine kinase mediated diseases.
Public/Granted literature
- US20090203688A1 HETEROCYCLIC COMPOUNDS Public/Granted day:2009-08-13
Information query
